TY - JOUR
T1 - Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy
AU - Figlioli, Gisella
AU - De Nicolo, Arcangela
AU - Catucci, Irene
AU - Manoukian, Siranoush
AU - Peissel, Bernard
AU - Azzollini, Jacopo
AU - Beltrami, Benedetta
AU - Bonanni, Bernardo
AU - Calvello, Mariarosaria
AU - Bondavalli, Davide
AU - Pasini, Barbara
AU - Vignolo Lutati, Francesca
AU - Ogliara, Paola
AU - Zuradelli, Monica
AU - Pensotti, Valeria
AU - De Vecchi, Giovanna
AU - Volorio, Sara
AU - Verderio, Paolo
AU - Pizzamiglio, Sara
AU - Matullo, Giuseppe
AU - Aneli, Serena
AU - Birolo, Giovanni
AU - Zanardi, Federica
AU - Tondini, Carlo
AU - Zambelli, Alberto
AU - Livraghi, Luca
AU - Franchi, Michela
AU - Radice, Paolo
AU - Peterlongo, Paolo
PY - 2021/1/30
Y1 - 2021/1/30
N2 - Germline pathogenic variants (PVs) in the BRCA1 or BRCA2 genes cause high breast cancer risk. Recurrent or founder PVs have been described worldwide including some in the Bergamo province in Northern Italy. The aim of this study was to compare the BRCA1/2 PV spectra of the Bergamo and of the general Italian populations. We retrospectively identified at five Italian centers 1019 BRCA1/2 PVs carrier individuals affected with breast cancer and representative of the heterogeneous national population. Each individual was assigned to the Bergamo or non-Bergamo cohort based on self-reported birthplace. Our data indicate that the Bergamo BRCA1/2 PV spectrum shows less heterogeneity with fewer different variants and an average higher frequency compared to that of the rest of Italy. Consistently, four PVs explained about 60% of all carriers. The majority of the Bergamo PVs originated locally with only two PVs clearly imported. The Bergamo BRCA1/2 PV spectrum appears to be private. Hence, the Bergamo population would be ideal to study the disease risk associated with local PVs in breast cancer and other disease-causing genes. Finally, our data suggest that the Bergamo population is a genetic isolate and further analyses are warranted to prove this notion.
AB - Germline pathogenic variants (PVs) in the BRCA1 or BRCA2 genes cause high breast cancer risk. Recurrent or founder PVs have been described worldwide including some in the Bergamo province in Northern Italy. The aim of this study was to compare the BRCA1/2 PV spectra of the Bergamo and of the general Italian populations. We retrospectively identified at five Italian centers 1019 BRCA1/2 PVs carrier individuals affected with breast cancer and representative of the heterogeneous national population. Each individual was assigned to the Bergamo or non-Bergamo cohort based on self-reported birthplace. Our data indicate that the Bergamo BRCA1/2 PV spectrum shows less heterogeneity with fewer different variants and an average higher frequency compared to that of the rest of Italy. Consistently, four PVs explained about 60% of all carriers. The majority of the Bergamo PVs originated locally with only two PVs clearly imported. The Bergamo BRCA1/2 PV spectrum appears to be private. Hence, the Bergamo population would be ideal to study the disease risk associated with local PVs in breast cancer and other disease-causing genes. Finally, our data suggest that the Bergamo population is a genetic isolate and further analyses are warranted to prove this notion.
U2 - 10.3390/cancers13030532
DO - 10.3390/cancers13030532
M3 - Article
C2 - 33573335
SN - 2072-6694
VL - 13
JO - Cancers
JF - Cancers
IS - 3
ER -